RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chongqing Zhifei Biological Products Co - Stock

Chongqing Zhifei Biological Products Co P/S 2024

Chongqing Zhifei Biological Products Co P/S

1.28

Ticker

300122.SZ

ISIN

CNE100000V20

As of Jul 1, 2024, Chongqing Zhifei Biological Products Co's P/S ratio stood at 1.28, a -60.25% change from the 3.22 P/S ratio recorded in the previous year.

The Chongqing Zhifei Biological Products Co P/S history

Chongqing Zhifei Biological Products Co Aktienanalyse

What does Chongqing Zhifei Biological Products Co do?

Chongqing Zhifei Biological Products Co Ltd is a Chinese company that was founded in 1998 and is headquartered in Chongqing, China. The company operates in the biotechnology sector and focuses on the research, development, and manufacturing of biological products. The company initially started in the 1990s as a small laboratory unit of Chongqing Lummy Pharmaceutical Co Ltd, a Chinese pharmaceutical company that mainly produced drugs. In 1998, the company decided to focus on the business of biological products and established Chongqing Zhifei Biological Products Co Ltd. The company's business model is based on the production of high-quality biopharmaceuticals and medical devices. Zhifei Biological Products offers a wide range of products such as vaccines, blood products, virus tests, medical devices, and diagnostic kits. The company has four main business fields: vaccines, blood products, test kits, and medical devices. Among vaccines, Zhifei Biological Products offers a range of vaccines for the prevention of infectious diseases such as hepatitis B, diphtheria, tetanus, and pertussis. The blood products manufactured by the company include intravenous immunoglobulins, plasma proteins, and albumin. Test kits include IgG antibody tests and quantitative PCR tests. Additionally, the company also offers a wide range of medical devices including blood collection kits, syringes, and infusion sets. The company has established itself in China as a trusted and reliable manufacturer of biopharmaceuticals and collaborates closely with various healthcare organizations to promote the prevention and control of infectious diseases. Zhifei Biological Products has also successfully exported its products to other countries and is active in the international market. In recent years, Zhifei Biological Products has also played a crucial role in the fight against the COVID-19 pandemic. The company, in collaboration with the Chinese military, developed and produced a COVID-19 vaccine in a short period of time. This vaccine has already been approved in countries such as Indonesia and Brazil and is being distributed worldwide. The company takes pride in not only manufacturing biopharmaceuticals but also contributing to creating a better world. It has a strong corporate culture and constantly promotes innovation and advanced technology. Chongqing Zhifei Biological Products Co Ltd is a key player in the Chinese biotechnology industry and plays an important role in improving global health. Chongqing Zhifei Biological Products Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Chongqing Zhifei Biological Products Co's P/S Ratio

Chongqing Zhifei Biological Products Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Chongqing Zhifei Biological Products Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Chongqing Zhifei Biological Products Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Chongqing Zhifei Biological Products Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Chongqing Zhifei Biological Products Co Stock

What is the price-to-earnings ratio of Chongqing Zhifei Biological Products Co?

The price-earnings ratio of Chongqing Zhifei Biological Products Co is currently 1.28.

How has the price-earnings ratio of Chongqing Zhifei Biological Products Co changed compared to last year?

The price-to-earnings ratio of Chongqing Zhifei Biological Products Co has increased by -60.25% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Chongqing Zhifei Biological Products Co high compared to other companies?

Yes, the price-to-earnings ratio of Chongqing Zhifei Biological Products Co is high compared to other companies.

How does an increase in the price-earnings ratio of Chongqing Zhifei Biological Products Co affect the company?

An increase in the price-earnings ratio of Chongqing Zhifei Biological Products Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Chongqing Zhifei Biological Products Co affect the company?

A decrease in the price-earnings ratio of Chongqing Zhifei Biological Products Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Chongqing Zhifei Biological Products Co?

Some factors that influence the price-earnings ratio of Chongqing Zhifei Biological Products Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Chongqing Zhifei Biological Products Co pay?

Over the past 12 months, Chongqing Zhifei Biological Products Co paid a dividend of 0.33 CNY . This corresponds to a dividend yield of about 1.19 %. For the coming 12 months, Chongqing Zhifei Biological Products Co is expected to pay a dividend of 0.42 CNY.

What is the dividend yield of Chongqing Zhifei Biological Products Co?

The current dividend yield of Chongqing Zhifei Biological Products Co is 1.19 %.

When does Chongqing Zhifei Biological Products Co pay dividends?

Chongqing Zhifei Biological Products Co pays a quarterly dividend. This is distributed in the months of September, September, August, July.

How secure is the dividend of Chongqing Zhifei Biological Products Co?

Chongqing Zhifei Biological Products Co paid dividends every year for the past 16 years.

What is the dividend of Chongqing Zhifei Biological Products Co?

For the upcoming 12 months, dividends amounting to 0.42 CNY are expected. This corresponds to a dividend yield of 1.49 %.

In which sector is Chongqing Zhifei Biological Products Co located?

Chongqing Zhifei Biological Products Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Zhifei Biological Products Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Zhifei Biological Products Co from 6/16/2023 amounting to 0.333 CNY, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.

When did Chongqing Zhifei Biological Products Co pay the last dividend?

The last dividend was paid out on 6/16/2023.

What was the dividend of Chongqing Zhifei Biological Products Co in the year 2023?

In the year 2023, Chongqing Zhifei Biological Products Co distributed 0.6 CNY as dividends.

In which currency does Chongqing Zhifei Biological Products Co pay out the dividend?

The dividends of Chongqing Zhifei Biological Products Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chongqing Zhifei Biological Products Co

Our stock analysis for Chongqing Zhifei Biological Products Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chongqing Zhifei Biological Products Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.